Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 3
1955 1
1956 3
1957 4
1958 8
1959 3
1960 8
1961 5
1962 4
1963 11
1964 6
1965 8
1967 7
1968 4
1969 8
1970 10
1971 15
1972 19
1973 13
1974 8
1975 10
1976 20
1977 29
1978 17
1979 29
1980 33
1981 39
1982 41
1983 47
1984 52
1985 43
1986 56
1987 77
1988 59
1989 79
1990 86
1991 85
1992 105
1993 109
1994 109
1995 134
1996 109
1997 145
1998 169
1999 150
2000 209
2001 186
2002 222
2003 260
2004 306
2005 389
2006 398
2007 457
2008 529
2009 597
2010 691
2011 734
2012 880
2013 976
2014 1033
2015 1031
2016 1141
2017 1208
2018 1245
2019 1256
2020 1477
2021 1615
2022 1638
2023 1690
2024 1348
2025 3

Text availability

Article attribute

Article type

Publication date

Search Results

21,020 results

Results by year

Filters applied: . Clear all
Page 1
Pathophysiology of Inflammatory Bowel Diseases.
Chang JT. Chang JT. N Engl J Med. 2020 Dec 31;383(27):2652-2664. doi: 10.1056/NEJMra2002697. N Engl J Med. 2020. PMID: 33382932 Review. No abstract available.
MET-dependent solid tumours - molecular diagnosis and targeted therapy.
Guo R, Luo J, Chang J, Rekhtman N, Arcila M, Drilon A. Guo R, et al. Among authors: chang j. Nat Rev Clin Oncol. 2020 Sep;17(9):569-587. doi: 10.1038/s41571-020-0377-z. Epub 2020 Jun 8. Nat Rev Clin Oncol. 2020. PMID: 32514147 Free PMC article. Review.
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization.
Baine MK, Hsieh MS, Lai WV, Egger JV, Jungbluth AA, Daneshbod Y, Beras A, Spencer R, Lopardo J, Bodd F, Montecalvo J, Sauter JL, Chang JC, Buonocore DJ, Travis WD, Sen T, Poirier JT, Rudin CM, Rekhtman N. Baine MK, et al. Among authors: chang jc. J Thorac Oncol. 2020 Dec;15(12):1823-1835. doi: 10.1016/j.jtho.2020.09.009. Epub 2020 Oct 1. J Thorac Oncol. 2020. PMID: 33011388 Free PMC article.
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial.
Zhou C, Chen G, Huang Y, Zhou J, Lin L, Feng J, Wang Z, Shu Y, Shi J, Hu Y, Wang Q, Cheng Y, Wu F, Chen J, Lin X, Wang Y, Huang J, Cui J, Cao L, Liu Y, Zhang Y, Pan Y, Zhao J, Wang L, Chang J, Chen Q, Ren X, Zhang W, Fan Y, He Z, Fang J, Gu K, Dong X, Zhang T, Shi W, Zou J; CameL Study Group. Zhou C, et al. Among authors: chang j. Lancet Respir Med. 2021 Mar;9(3):305-314. doi: 10.1016/S2213-2600(20)30365-9. Epub 2020 Dec 18. Lancet Respir Med. 2021. PMID: 33347829 Clinical Trial.
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.
Cheng Y, Spigel DR, Cho BC, Laktionov KK, Fang J, Chen Y, Zenke Y, Lee KH, Wang Q, Navarro A, Bernabe R, Buchmeier EL, Chang JW, Shiraishi Y, Goksu SS, Badzio A, Shi A, Daniel DB, Hoa NTT, Zemanova M, Mann H, Gowda H, Jiang H, Senan S; ADRIATIC Investigators. Cheng Y, et al. Among authors: chang jw. N Engl J Med. 2024 Oct 10;391(14):1313-1327. doi: 10.1056/NEJMoa2404873. Epub 2024 Sep 13. N Engl J Med. 2024. PMID: 39268857 Clinical Trial.
The Blood Biomarkers of Thyroid Cancer.
Wang W, Chang J, Jia B, Liu J. Wang W, et al. Among authors: chang j. Cancer Manag Res. 2020 Jul 6;12:5431-5438. doi: 10.2147/CMAR.S261170. eCollection 2020. Cancer Manag Res. 2020. PMID: 32753960 Free PMC article. Review.
21,020 results
You have reached the last available page of results. Please see the User Guide for more information.